Traditional Chinese medicine composition for treating chronic virulent hepatitis b and preparation method thereof

A hepatitis B, viral technology, applied in the field of Chinese patent medicines for the treatment of hepatitis B, can solve the problem of high recurrence rate, and achieve the effect of strict compatibility, good anti-hepatitis B activity, and definite curative effect

Inactive Publication Date: 2015-06-17
杨道坤
View PDF2 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

High relapse rate after discontinuation of short-term treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine composition for treating chronic virulent hepatitis b and preparation method thereof
  • Traditional Chinese medicine composition for treating chronic virulent hepatitis b and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0013] Weigh the raw materials (grams) according to the following proportions:

[0014] 1. Astragalus 65, Salvia 65, Ligustrum lucidum 50, Lycium barbarum 50, Smilax smilax 50, Bupleurum 40, Poria 40, Schisandra 40, Codonopsis 40, Pinellia 40, Chinese yam 40, Banlangen 40, Atractylodes macrocephala 40, Curcuma 40 , Radix Paeoniae Alba 40, Hedyotis diffusa 40, Angelica 40, Chenpi 40, Honeysuckle 40, Polygonatum 40, and Hawthorn 30;

[0015] 2. Astragalus 55, Salvia 58, Ligustrum lucidum 40, Lycium barbarum 40, Smilax 40, Bupleurum 30, Poria 32, Schisandra 30, Codonopsis 30, Pinellia 28, Yam 28, Radix Radix 30, Atractylodes macrocephala 32, Curcuma 30 , Radix Paeoniae Alba 32, Hedyotis diffusa 30, Angelica 32, Tangerine Peel 35, Honeysuckle 35, Polygonatum 30, and Hawthorn 25;

[0016] 3. Astragalus 72, Salvia 75, Ligustrum lucidum 56, Lycium barbarum 58, Smilax smilax 58, Bupleurum 52, Poria cocos 48, Schisandra 52, Codonopsis 58, Pinellia 56, Chinese yam 58, Banlangen 46, Atr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a traditional Chinese medicine composition for treating chronic virulent hepatitis b and a preparation method thereof, and belongs to the technical field of Chinese patent medicine for treating hepatitis b. According to the technical scheme, the traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 55-72 parts of astragalus membranaceus, 58-75 parts of salvia miltiorrhiza, 40-56 parts of glossy privet fruit, 40-58 parts of Chinese wolfberry, 40-58 parts of rhizoma smilacis glabrae, 30-52 parts of radix bupleuri, 32-48 parts of poria cocos, 30-52 parts of schisandra chinensis, 30-58 parts of codonopsis pilosula, 28-56 parts of pinellia ternate, 28-58 parts of Chinese yam, 30-46 parts of isatis roots, 32-48 parts of bighead atractylodes rhizome, 30-46 parts of curcuma aromatica, 32-46 parts of radix paeoniae alba, 30-49 parts of oldenlandia diffusa, 32-49 parts of angelica sinensis, 35-46 parts of pericarpium citri reticulatae, 35-50 parts of honeysuckle, 30-44 parts of polygonatum sibiricum and 25-35 parts of coke hawthorn. The invention further discloses the preparation method for the traditional Chinese medicine composition for treating chronic virulent hepatitis b. The traditional Chinese medicine composition is prepared from traditional Chinese medicinal materials, has no toxic or side effect, and is low in cost. Animal experiments and clinical application studies find that the traditional Chinese medicine composition has good anti-HBV activity.

Description

technical field [0001] The invention belongs to the technical field of Chinese patent medicines for treating hepatitis B, and in particular relates to a traditional Chinese medicine composition for treating chronic viral hepatitis B and a preparation method thereof. Background technique [0002] Chronic hepatitis B can be diagnosed if there is a history of hepatitis B or HBVsAg carrier in the past, or the course of acute hepatitis is more than half a year, but there are still symptoms, signs and liver function abnormalities of hepatitis. The date of onset is unknown or there is no history of hepatitis, but imaging, laparoscopy, or liver biopsy pathological examinations are consistent with chronic hepatitis changes, or a corresponding diagnosis can be made based on comprehensive analysis of symptoms, signs, and laboratory tests. According to the 1994 World Congress of Digestive Diseases, the development of chronic hepatitis B is graded and staged, and the degree of the diseas...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61P1/16A61P31/20
Inventor 杨道坤梁海军崔艳慧高海丽王新伟乔立新乔汉臣
Owner 杨道坤
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap